Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings

Shares (Q2 2026)
1,636
Value
$517.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LGND by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,636$517.1K<0.1%+425+35.1%AddedHolders
Q1 20261,211$241.8K<0.1%−25−2.0%ReducedHolders
Q4 20251,236$233.7K<0.1%−160−11.5%ReducedHolders
Q3 20251,396$247.3K<0.1%−2,377−63.0%ReducedHolders
Q2 20253,773$428.9K<0.1%−286−7.0%ReducedHolders
Q1 20254,059$426.8K<0.1%+3,301+435.5%AddedHolders
Q4 2024758$81.2K<0.1%+98+14.8%AddedHolders
Q3 2024660$66.1K<0.1%+12+1.9%AddedHolders
Q2 2024648$54.6K<0.1%−12−1.8%ReducedHolders
Q1 2024660$48.2K<0.1%+48+7.8%AddedHolders
Q4 2023612$43.7K<0.1%+531+655.6%AddedHolders
Q3 202381$4.85K<0.1%−194−70.5%ReducedHolders
Q2 2023275$19.8K<0.1%−6−2.1%ReducedHolders
Q1 2023281$20.7K<0.1%+245+680.6%AddedHolders
Q4 202236$2.40K<0.1%−16−30.8%ReducedHolders
Q3 202252$5.00K<0.1%−13−20.0%ReducedHolders
Q2 202265$6.00K<0.1%−8−11.0%ReducedHolders
Q1 202273$8.00K<0.1%−239−76.6%ReducedHolders
Q4 2021312$48.0K<0.1%+44+16.4%AddedHolders
Q3 2021268$38.0K<0.1%−600−69.1%ReducedHolders
Q2 2021868$114.0K<0.1%−47−5.1%ReducedHolders
Q1 2021915$140.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.